Projects per year
Personal profile
Research interests
Biotechnology - Deoxyribonucleic acid (DNA) replication
Biological Sciences - Cell cycle control
Biotechnology - Cancer
Biotechnology - Biotechnology
Biological Sciences - Cell cycle control
Biotechnology - Cancer
Biotechnology - Biotechnology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Related documents
Education/Academic qualification
PhD in Biology, PhD, Brown University
1993
Fingerprint
Dive into the research topics where Chun LIANG is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of an inhaled liposomal drug based on the new anticancer targets DNA replication-initiation proteins
LIANG, C. (PI), LIU, X. (CoI), SU, H. (CoI), YANG, L. (CoI) & ZHANG, Z. (CoI)
Department of Science and Technology of Guangdong Province
12/09/22 → 11/09/26
Project: Research
-
The Roles, Mechanisms and Regulation of NOC3 Dimerization and ORC Dimerization in Yeast and Human Cells
LIANG, C. (PI)
1/07/21 → 30/06/24
Project: Research
-
创新靶标高效低毒抗癌一类新药EZ-001的临床前研究
LIANG, C. (PI), JIANG, H. (CoI), LIANG, L. (CoI) & CHEUNG, W. (CoI)
1/04/16 → 31/03/19
Project: Research
-
-
Identifying genetic susceptibility loci associated with human coronary artery disease
Zahid, A., Batool, A., Wajid, A., Wu, Y., Liang, C., Khan, M. A., Ullah, A., Sahibzada, K. I. & Xue, H., Jan 2025, In: PLoS ONE. 20, 1, e0315460.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Non-clinical and clinical research on innovative DNA replication-initiation proteins (DRIPs) inhibitors derived from natural products as anticancer drugs
LIANG, C., Apr 2025.Research output: Contribution to conference › Conference Paper › peer-review
-
Preclinical and Clinical Studies of First-in-class DRIP Inhibitors as Highly Efficacious Anticancer Drug Candidates
LIANG, C., Mar 2025.Research output: Contribution to conference › Conference Paper › peer-review
-
Safety and Preliminary Efficacy of a First-in-Class DRIP Inhibitor EN002 Topical Gel in Non-melanoma Skin Cancer and Actinic Keratosis: An International Phase I Study
WANG, B., ZOU, L., WANG, X., LIANG, C., ZHAO, Z., WU, M. & YAN, J., May 2025.Research output: Contribution to conference › Conference Paper › peer-review
-
The ErChen Decoction and Its Active Compounds Ameliorate Non-Alcoholic Fatty Liver Disease Through Activation of the AMPK Signaling Pathway
Wang, Y., Liang, Y., Cheung, M. H., Wang, X., Mo, H., Gan, J., Yang, W., Guo, J. & Liang, C., 11 Nov 2025, In: Pharmaceuticals. 18, 11, 18 p., 1707.Research output: Contribution to journal › Journal Article › peer-review
Open Access
Activities
- 4 Editorial work
-
Frontiers Cell Dev. Biol. (Journal)
LIANG, C. (Associate Editor)
1 Jan 2016 → …Activity: Publication peer-review and editorial work › Editorial work
-
J. Biomed. Tech. Res. (Journal)
LIANG, C. (Chief Editor)
1 Dec 2013 → …Activity: Publication peer-review and editorial work › Editorial work
-
Chinese Journal of Biology (Journal)
LIANG, C. (Editorial Board Member)
1 May 2013 → …Activity: Publication peer-review and editorial work › Editorial work
-
BMC Molecular Biology (Journal)
LIANG, C. (Associate Editor)
1 Sept 2008 → …Activity: Publication peer-review and editorial work › Editorial work
Awards
-
Gold Metal, the 50th Geneva international exhibition of inventions
LIANG, C. (Recipient), Apr 2025
Prize: Honorary Award
-
-
-
Excellent Award (the highest) of Disruptive Innovation Technology
LIANG, C. (Recipient), Apr 2023
Prize: Honorary Award
-
National Foreign Experts Program of the Ministry of Science and Technology of China
LIANG, C. (Recipient), Aug 2023
Prize: Research Fellowship